Hyderabad Telangana, India

Raghava Choudary Palacharla

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Suven Life Sciences Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raghava Choudary Palacharla. Retrieved from https://idiyas.com/inventor/raghava-choudary-palacharla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raghava Choudary Palacharla: Innovator in Pharmaceutical Science

Introduction

Raghava Choudary Palacharla is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that act as muscarinic M1 receptor positive allosteric modulators.

Latest Patents

Raghava holds a patent for his invention titled "Substituted azacycles as muscarinic M1 receptor positive allosteric modulators." This patent relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers, or pharmaceutically acceptable salts thereof. The invention describes methods of preparation, pharmaceutical compositions, combinations, and the use of these compounds as M1 PAMs. He has 1 patent to his name.

Career Highlights

Raghava Choudary Palacharla is associated with Suven Life Sciences Limited, where he applies his expertise in pharmaceutical research and development. His work focuses on innovative solutions that enhance therapeutic efficacy.

Collaborations

Raghava has collaborated with notable colleagues such as Ramakrishna Nirogi and Anil Karbhari Shinde, contributing to advancements in their shared field of research.

Conclusion

Raghava Choudary Palacharla is a distinguished inventor whose work in pharmaceutical science continues to impact the industry positively. His innovative approach to drug development exemplifies the importance of research in enhancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…